Authors
Fengxue Bao, Yuxin Jin, Rong Wang, Weiting Wang, Shanshan Zhu, Shuo Yang, Jin Cao, Aili Yang, Guohong Zhao, Bin Gao
Published in
European journal of endocrinology. Nov 16, 2026. Epub Nov 16, 2026.
Abstract
The reproductive-endocrine effects of GLP-1 receptor agonists (GLP-1RAs) in polyendocrine metabolic ovarian syndrome (PMOS; formerly polycystic ovary syndrome) and their relationship to metabolic improvement remain uncertain.
We performed a frequentist random-effects network meta-analysis of randomized trials comparing GLP-1RA, metformin, their combination, and placebo. An adapted CINeMA assessment evaluated certainty about any difference. Exploratory meta-regressions examined metabolic-endocrine associations; drug-target Mendelian randomization (MR) examined genetically proxied GLP1R expression.
Forty-two reports published during 2000-2026 represented 35 trials and 2,580 randomized participants; 34 trials contributed quantitative data. Versus metformin, combination therapy lowered HOMA-IR (MD -0.91, 95% CI -1.22 to -0.60) and free androgen index (MD -2.46, -3.97 to -0.96), and increased SHBG (MD 10.21 nmol/L, 6.54-13.89). Ovulation favored combination therapy (OR 16.12, 95% CI 2.87-90.63), but was source-sensitive; pregnancy comparisons remained imprecise. Of 186 comparisons, certainty was moderate for 15, low for 21, and very low for 150. No meta-regression association survived multiplicity adjustment. MR associated genetically proxied GLP1R expression with lower total testosterone (β -0.049, 95% CI -0.076 to -0.022), lower bioavailable testosterone, and higher SHBG.
Combination therapy may improve selected short-term metabolic and androgen-related measures in women with PMOS and overweight or obesity. Genetic findings provide complementary evidence linking genetically proxied GLP1R expression to androgen-related traits. Larger, longer-term trials are needed to determine whether these changes translate into reproductive and patient-important benefits.
PMID:
43038352
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0